Total Payments
$3,127
2024 Payments
$2,024
Companies
36
Transactions
110
Medicare Patients
755
Medicare Billing
$58,188
Payment Breakdown by Category
Food & Beverage$2,852 (91.2%)
Education$274.98 (8.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,852 | 106 | 91.2% |
| Education | $274.98 | 4 | 8.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $313.75 | 9 | $0 (2024) |
| Janssen Biotech, Inc. | $277.18 | 6 | $0 (2024) |
| Merck Sharp & Dohme LLC | $205.08 | 11 | $0 (2024) |
| PFIZER INC. | $198.05 | 14 | $0 (2024) |
| Astellas Pharma US Inc | $191.87 | 5 | $0 (2024) |
| ABBVIE INC. | $147.22 | 3 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $144.84 | 8 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $143.19 | 2 | $0 (2024) |
| EMD Serono, Inc. | $125.00 | 1 | $0 (2023) |
| Tempus AI, Inc | $125.00 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,024 | 75 | AstraZeneca Pharmaceuticals LP ($235.17) |
| 2023 | $1,010 | 33 | Astellas Pharma US Inc ($154.92) |
| 2021 | $93.31 | 2 | Novo Nordisk Inc ($93.31) |
All Payment Transactions
110 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG | Food and Beverage | In-kind items and services | $22.78 | General |
| Category: ONCOLOGY | ||||||
| 12/09/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: ONCOLOGY | ||||||
| 12/03/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $21.21 | General |
| Category: ONCOLOGY | ||||||
| 11/26/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: ONCOLOGY | ||||||
| 11/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | VONVENDI (Biological) | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: HEMATOLOGY | ||||||
| 11/13/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $20.43 | General |
| Category: ONCOLOGY | ||||||
| 11/12/2024 | Astellas Pharma US Inc | Padcev (Drug) | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: Oncology | ||||||
| 11/07/2024 | Incyte Corporation | MONJUVI (Drug), PEMAZYRE | Food and Beverage | Cash or cash equivalent | $16.47 | General |
| Category: Oncology | ||||||
| 11/03/2024 | Takeda Pharmaceuticals U.S.A., Inc. | FRUZAQLA (Drug) | Food and Beverage | In-kind items and services | $75.00 | General |
| Category: ONCOLOGY | ||||||
| 11/03/2024 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $33.34 | General |
| 11/02/2024 | Janssen Biotech, Inc. | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 11/02/2024 | ABBVIE INC. | ELAHERE (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: ONCOLOGY | ||||||
| 11/02/2024 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Oncology | ||||||
| 11/02/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 11/02/2024 | Gilead Sciences, Inc. | Trodelvy (Drug) | Food and Beverage | In-kind items and services | $60.00 | General |
| Category: ONC | ||||||
| 10/29/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: ONCOLOGY | ||||||
| 10/22/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: ONCOLOGY | ||||||
| 10/18/2024 | Stemline Therapeutics Inc. | Orserdu (Drug) | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: Oncology | ||||||
| 10/10/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $21.87 | General |
| Category: Oncology | ||||||
| 10/01/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: ONCOLOGY | ||||||
| 09/26/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $20.68 | General |
| Category: ONCOLOGY | ||||||
| 09/24/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $26.15 | General |
| 09/19/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $27.41 | General |
| Category: Oncology | ||||||
| 09/18/2024 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug) | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: Oncology | ||||||
| 09/18/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 19 | 20 | $4,360 | $80.00 |
| 2022 | 2 | 43 | 101 | $10,562 | $431.38 |
| 2021 | 3 | 98 | 199 | $15,843 | $1,078 |
| 2020 | 14 | 595 | 2,206 | $166,931 | $56,599 |
Total Patients
755
Total Services
2,526
Medicare Billing
$58,188
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93005 | Routine electrocardiogram (ecg) using at least 12 leads with tracing | Office | 2023 | 19 | 20 | $4,360 | $80.00 | 1.8% |
| 85610 | Blood test, clotting time | Office | 2022 | 11 | 64 | $2,496 | $271.99 | 10.9% |
| 93005 | Routine electrocardiogram (ecg) using at least 12 leads with tracing | Office | 2022 | 32 | 37 | $8,066 | $159.39 | 2.0% |
| 85610 | Blood test, clotting time | Office | 2021 | 21 | 115 | $4,485 | $493.35 | 11.0% |
| 83037 | Hemoglobin a1c level, by device for home use | Office | 2021 | 33 | 38 | $1,330 | $368.98 | 27.7% |
| 93005 | Routine electrocardiogram (ekg) with tracing using at least 12 leads | Office | 2021 | 44 | 46 | $10,028 | $215.66 | 2.2% |
| J0897 | Injection, denosumab, 1 mg | Office | 2020 | 15 | 1,320 | $31,830 | $20,589 | 64.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 190 | 303 | $66,199 | $18,522 | 28.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 186 | 303 | $44,267 | $12,116 | 27.4% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 28 | 30 | $2,020 | $1,756 | 86.9% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 17 | 17 | $4,119 | $1,030 | 25.0% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2020 | 16 | 19 | $5,383 | $749.38 | 13.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 31 | 33 | $1,044 | $557.02 | 53.3% |
| 73560 | X-ray of knee, 1 or 2 views | Office | 2020 | 15 | 15 | $2,852 | $344.54 | 12.1% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 19 | 31 | $1,675 | $275.00 | 16.4% |
| 73030 | X-ray of shoulder, minimum of 2 views | Office | 2020 | 12 | 13 | $3,054 | $248.41 | 8.1% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 21 | 22 | $2,092 | $186.90 | 8.9% |
| 85610 | Blood test, clotting time | Office | 2020 | 17 | 30 | $1,170 | $128.70 | 11.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2020 | 15 | 57 | $913.20 | $57.94 | 6.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 13 | 13 | $312.00 | $38.22 | 12.3% |
About John Vipperman, PAC
John Vipperman, PAC is a Medical healthcare provider based in Cody, Wyoming. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/16/2005. The National Provider Identifier (NPI) number assigned to this provider is 1992787980.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, John Vipperman, PAC has received a total of $3,127 in payments from pharmaceutical and medical device companies, with $2,024 received in 2024. These payments were reported across 110 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($2,852).
As a Medicare-enrolled provider, Vipperman has provided services to 755 Medicare beneficiaries, totaling 2,526 services with total Medicare billing of $58,188. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Medical
- Other Specialties Medical
- Location Cody, WY
- Active Since 11/16/2005
- Last Updated 01/30/2020
- Taxonomy Code 363AM0700X
- Entity Type Individual
- NPI Number 1992787980
Products in Payments
- KEYTRUDA (Biological) $189.56
- IMFINZI (Biological) $162.60
- Padcev (Drug) $148.91
- LIBTAYO (Biological) $143.19
- BAVENCIO (Drug) $125.00
- ELAHERE (Drug) $125.00
- TAGRISSO (Drug) $125.00
- IMBRUVICA (Drug) $117.61
- Doptelet (Drug) $104.77
- Ozempic (Drug) $93.31
- XTANDI (Drug) $79.10
- OPDUALAG (Drug) $78.75
- SCEMBLIX (Drug) $77.94
- FRUZAQLA (Drug) $75.00
- IBRANCE (Drug) $70.88
- ORGOVYX (Drug) $64.31
- Trodelvy (Drug) $60.00
- MONJUVI (Drug) $50.73
- OPDIVO (Biological) $50.66
- OJJAARA (Drug) $47.76
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.